MedPath

Prixlae

Brand Name: Prixlae

Generic Name: Cetirizine Hyrochloride

Active
Registration Number

DRP-990

Dosage Form

Syrup

Issuance Date

December 1, 2021

Expiry Date

September 7, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1mg / mL
PackagingPlastic Bottle x 60 mL / Prixlae

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
H1 - RECEPTOR ANTAGONIST (ANTIHISTAMINE)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cetirizine HyrochlorideActive
Monograph: cetirizine hyrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform